Apis Flagship Fund Outperforms in Q4 2025, Cites Stock Picks and Strategy
The Apis Flagship Fund reported robust quarterly and annual gains for 2025, significantly beating global benchmarks. While highlighting its performance drivers, the fund's investor letter also discussed its position on gene therapy firm uniQure (QURE).